This inventor holds 1 USPTO granted patent. Top assignee: Evident Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mizuki Notoya: Innovator in Endoscopic Technology
Introduction
Mizuki Notoya is a prominent inventor based in Nagano, Japan. She has made significant contributions to the field of medical technology, particularly in the development of endoscopic devices. Her innovative work has led to advancements that enhance the capabilities of endoscopic systems.
Latest Patents
Mizuki Notoya holds a patent for an endoscope device, endoscope system, convergence angle changing method, and computer-readable medium. This endoscope device features an imaging optical system that includes two incident light paths formed by two optical systems with optical axes eccentric to the imaging center of an imaging element. The device incorporates an optical action member designed to change the convergence angle, along with a processor that controls the state of the optical action member within the imaging optical system. The processor is responsible for adjusting the convergence angle by managing the state of the optical action member.
Career Highlights
Mizuki Notoya is currently associated with Evident Corporation, where she continues to work on innovative solutions in the medical technology sector. Her expertise and dedication to her field have positioned her as a key player in advancing endoscopic technology.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Mizuki Notoya's contributions to endoscopic technology exemplify her commitment to innovation in the medical field. Her patent and ongoing work at Evident Corporation highlight her role as a leading inventor in this important area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile